Filtros de búsqueda

Lista de obras de Eleonora Scorletti

Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected]

artículo científico publicado en 2014

Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study.

artículo científico publicado en 2017

Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study.

artículo científico publicado en 2017

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study

artículo científico publicado en 2014

Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis.

artículo científico publicado en 2016

Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD.

artículo científico publicado en 2017

Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor thErapy trial (WELCOME) trial.

artículo científico publicado en 2016

Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial

artículo científico publicado en 2015

Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression

scientific article published on 24 December 2015

Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments

artículo científico publicado el 6 de septiembre de 2011

Nonalcoholic Fatty Liver Disease and Reduced Serum Vitamin D3 Levels ⬇️

artículo científico publicado el 7 de junio de 2013

Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease ⬇️

artículo científico publicado el 1 de enero de 2013

Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.

artículo científico

Reply to: "Fructose, uric acid and zonal differences in NASH"

artículo científico publicado en 2017

Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents

artículo científico publicado en 2017

Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial

artículo científico publicado en 2015

Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda